Activation of the Complement System in Patients with Cancer Cachexia
Systemic inflammation is thought to underlie many of the metabolic manifestations of cachexia in cancer patients. The complement system is an important component of innate immunity that has been shown to contribute to metabolic inflammation. We hypothesized that systemic inflammation in patients wit...
Guardado en:
Autores principales: | Min Deng, Rianne D. W. Vaes, Annemarie A. J. H. M. van Bijnen, Steven W. M. Olde Damink, Sander S. Rensen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/50e88f3df25541a1969440aef39fbfde |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amelioration of muscle wasting by gintonin in cancer cachexia
por: Yoseph Toni Wijaya, et al.
Publicado: (2021) -
Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
por: Hayashi N, et al.
Publicado: (2021) -
Impact of TNF-α Gene Polymorphisms on Pancreatic and Non-Small Cell Lung Cancer-Induced Cachexia in Adult Egyptian Patients: A Focus on Pathogenic Trajectories
por: Rana Yehia, et al.
Publicado: (2021) -
Downregulation of miR-29c promotes muscle wasting by modulating the activity of leukemia inhibitory factor in lung cancer cachexia
por: Kairu Xie, et al.
Publicado: (2021) -
Sarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: review
por: Tatyana S. Dikova, et al.
Publicado: (2021)